Publications reviewed for GINA Workshop Report: Update 2004
Publication Date from 2003/01/01 to 2003/12/31
1.
Agertoft L, Laulund LW, Harrison LI, Pedersen S. Influence of particle size on lung
deposition and pharmacokinetics of beclomethasone dipropionate in children. Pediatr Pulmonol
2003;35(3):192-199.
2.
Ahlbach S, Usadel KH, Kaufmann R, Boehncke WH. [The selective cyclooxygenase-2
inhibitor celecoxib is a safe alternative in patients with pseudo-allergic reactions to nonsteroidal
anti-inflammatory drugs]. Med Klin (Munich) 2003;98(5):242-244.
3.
Ahn HC, Lee YC. The clearance of theophylline is increased during the initial period of
tuberculosis treatment. Int J Tuberc Lung Dis 2003;7(6):587-591.
4.
Allen SC, Jain M, Ragab S, Malik N. Acquisition and short-term retention of inhaler
techniques require intact executive function in elderly subjects. Age Ageing 2003;32(3):299-302.
5.
Allen-Ramey FC, Duong PT, Goodman DC, Sajjan SG, Nelsen LM, Santanello NC,
Markson LE. Treatment effectiveness of inhaled corticosteroids and leukotriene modifiers for
patients with asthma: an analysis from managed care data. Allergy Asthma Proc 2003;24(1):43-51.
6.
Amirav I, Mansour Y, Tiosano T, Chamny S, Chirurg S, Oren S, Grossman Z, Kahana L,
Kahan E, Newhouse MT. Safety of inhaled corticosteroids delivered by plastic and metal spacers.
Arch Dis Child 2003;88(6):527-528.
7.
Amirav I, Balanov I, Gorenberg M, Groshar D, Luder AS. Nebuliser hood compared to
mask in wheezy infants: aerosol therapy without tears! Arch Dis Child 2003;88(8):719-723.
8.
Andre C, Perrin-Fayolle M, Grosclaude M, Couturier P, Basset D, Cornillon J, Piperno D,
Girodet B, Sanchez R, Vallon C, Bellier P, Nasr M. A double-blind placebo-controlled evaluation
of sublingual immunotherapy with a standardized ragweed extract in patients with seasonal rhinitis.
Evidence for a dose-response relationship. Int Arch Allergy Immunol 2003;131(2):111-118.
9.
Ankerst J, Persson G, Weibull E. Tolerability of a high dose of budesonide/formoterol in a
single inhaler in patients with asthma. Pulm Pharmacol Ther 2003;16(3):147-151.
10.
Arbes SJ, Jr., Sever M, Archer J, Long EH, Gore JC, Schal C, Walter M, Nuebler B,
Vaughn B, Mitchell H, Liu E, Collette N, Adler P, Sandel M, Zeldin DC. Abatement of cockroach
allergen (Bla g 1) in low-income, urban housing: A randomized controlled trial. J Allergy Clin
Immunol 2003;112(2):339-345.
11.
Arshad SH, Bateman B, Matthews SM. Primary prevention of asthma and atopy during
childhood by allergen avoidance in infancy: a randomised controlled study. Thorax
2003;58(6):489-493.
12.
Asmus MJ, Hendeles L. Levalbuterol nebulizer solution: is it worth five times the cost of
albuterol? Pharmacotherapy 2000;20(2):123-129.
13.
Babu KS, Woodcock DA, Smith SE, Staniforth JN, Holgate ST, Conway JH. Inhaled
synthetic surfactant abolishes the early allergen-induced response in asthma. Eur Respir J
2003;21(6):1046-1049.
14.
Baena-Cagnani CE, Berger WE, DuBuske LM, Gurne SE, Stryszak P, Lorber R, Danzig M.
Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2agonists in patients with seasonal allergic rhinitis and asthma. Int Arch Allergy Immunol
2003;130(4):307-313.
15.
Baker R, Fraser RC, Stone M, Lambert P, Stevenson K, Shiels C. Randomised controlled
trial of the impact of guidelines, prioritized review criteria and feedback on implementation of
recommendations for angina and asthma. Br J Gen Pract 2003;53(489):284-291.
16.
Banov C, Howland WC, 3rd, Lumry WR, Parasuraman B, Uryniak T, Liljas B. Budesonide
turbuhaler delivered once daily improves health-related quality of life in adult patients with nonsteroid-dependent asthma. Allergy Asthma Proc 2003;24(2):129-136.
17.
Barbanel D, Eldridge S, Griffiths C. Can a self-management programme delivered by a
community pharmacist improve asthma control? A randomised trial. Thorax 2003;58(10):851-854.
18.
Barben JU, Roberts M, Robertson CF. Effect of detergent-coated versus non-coated spacers
on bronchodilator response in children with asthma. J Paediatr Child Health 2003;39(4):270-273.
19.
Barczyk A, Pierzchala W, Sozanska E. Interleukin-17 in sputum correlates with airway
hyperresponsiveness to methacholine. Respir Med 2003;97(6):726-733.
20.
Baumgartner RA, Martinez G, Edelman JM, Rodriguez Gomez GG, Bernstein M, Bird S,
Angner R, Polis A, Dass SB, Lu S, Reiss TF. Distribution of therapeutic response in asthma control
between oral montelukast and inhaled beclomethasone. Eur Respir J 2003;21(1):123-128.
21.
Beeh KM, Beier J, Kornmann O, Meier C, Taeumer T, Buhl R. A single nasal allergen
challenge increases induced sputum inflammatory markers in non-asthmatic subjects with seasonal
allergic rhinitis: correlation with plasma interleukin-5. Clin Exp Allergy 2003;33(4):475-482.
22.
Bellia V, Catalano F, Scichilone N, Incalzi RA, Spatafora M, Vergani C, Rengo F. Sleep
disorders in the elderly with and without chronic airflow obstruction: the SARA study. Sleep
2003;26(3):318-323.
23.
Bender BG, Ellison MC, Gleason M, Murphy JR, Sundstrom DA, Szefler SJ. Minimizing
attrition in a long-term clinical trial of pediatric asthma. Ann Allergy Asthma Immunol
2003;91(2):168-176.
24.
Berger W, Gupta N, McAlary M, Fowler-Taylor A. Evaluation of long-term safety of the
anti-IgE antibody, omalizumab, in children with allergic asthma. Ann Allergy Asthma Immunol
2003;91(2):182-188.
25.
Berges-Gimeno MP, Simon RA, Stevenson DD. Early effects of aspirin desensitization
treatment in asthmatic patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma
Immunol 2003;90(3):338-341.
26.
Berkman N, Avital A, Bardach E, Springer C, Breuer R, Godfrey S. The effect of
montelukast on bronchial provocation tests and exhaled nitric oxide levels in asthmatic patients. Isr
Med Assoc J 2003;5(11):778-781.
27.
Bernstein DI, Karnani R, Biagini RE, Bernstein CK, Murphy K, Berendts B, Bernstein JA,
Bernstein L. Clinical and occupational outcomes in health care workers with natural rubber latex
allergy. Ann Allergy Asthma Immunol 2003;90(2):209-213.
28.
Bisca N, Cernatescu I, Dragomir D, Iacomi A, Mirceau M, Orascanu D. Comparison of the
efficacy and safety of beclometasone dipropionate suspension for nebulization and beclometasone
dipropionate via a metered-dose inhaler in paediatric patients with moderate to severe exacerbation
of asthma. Respir Med 2003;97 Suppl B:S15-20.
29.
Bisgaard H. A randomized trial of montelukast in respiratory syncytial virus
postbronchiolitis. Am J Respir Crit Care Med 2003;167(3):379-383.
30.
Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening AP, Haahtela T, Holgate ST,
Picado C, Menten J, Dass SB, Leff JA, Polos PG. Montelukast and fluticasone compared with
salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double
blind, randomised, comparative trial. Bmj 2003;327(7420):891.
31.
Black CP. Systematic review of the biology and medical management of respiratory
syncytial virus infection. Respir Care 2003;48(3):209-231; discussion 231-203.
32.
Blackhall K, Appleton S, Cates CJ. Ionisers for chronic asthma. Cochrane Database Syst
Rev 2003(3):CD002986.
33.
Boniface S, Koscher V, Mamessier E, El Biaze M, Dupuy P, Lorec AM, Guillot C, Badier
M, Bongrand P, Vervloet D, Magnan A. Assessment of T lymphocyte cytokine production in
induced sputum from asthmatics: a flow cytometry study. Clin Exp Allergy 2003;33(9):1238-1243.
34.
Boonsawat W, Charoenratanakul S, Pothirat C, Sawanyawisuth K, Seearamroongruang T,
Bengtsson T, Brander R, Selroos O. Formoterol (OXIS) Turbuhaler as a rescue therapy compared
with salbutamol pMDI plus spacer in patients with acute severe asthma. Respir Med
2003;97(9):1067-1074.
35.
Bousquet J, Meziane H, Chanez P, Mueser M, Umile A. The response of two different
dosages of beclometasone dipropionate suspension for nebulization versus a standard dose of
beclometasone dipropionate via a metered-dose inhaler on bronchoprovocation testing in adults
with asthma. Respir Med 2003;97 Suppl B:S11-14.
36.
Brambilla C, Le Gros V, Bourdeix I. Formoterol 12 microg BID administered via singledose dry powder inhaler in adults with asthma suboptimally controlled with salmeterol or ondemand salbutamol: a multicenter, randomized, open-label, parallel-group study. Clin Ther
2003;25(7):2022-2036.
37.
Broeders ME, Molema J, Vermue NA, Folgering HT. In Check Dial: accuracy for Diskus
and Turbuhaler. Int J Pharm 2003;252(1-2):275-280.
38.
Broeders ME, Molema J, Hop WC, Folgering HT. Inhalation profiles in asthmatics and
COPD patients: reproducibility and effect of instruction. J Aerosol Med 2003;16(2):131-141.
39.
Buchvald F, Bisgaard H. Comparisons of the complementary effect on exhaled nitric oxide
of salmeterol vs montelukast in asthmatic children taking regular inhaled budesonide. Ann Allergy
Asthma Immunol 2003;91(3):309-313.
40.
Buhl R, Creemers JP, Vondra V, Martelli NA, Naya IP, Ekstrom T. Once-daily
budesonide/formoterol in a single inhaler in adults with moderate persistent asthma. Respir Med
2003;97(4):323-330.
41.
Bukstein DA, Luskin AT, Bernstein A. "Real-world" effectiveness of daily controller
medicine in children with mild persistent asthma. Ann Allergy Asthma Immunol 2003;90(5):543549.
42.
Bukstein DA, Bratton DL, Firriolo KM, Estojak J, Bird SR, Hustad CM, Edelman JM.
Evaluation of parental preference for the treatment of asthmatic children aged 6 to 11 years with
oral montelukast or inhaled cromolyn: a randomized, open-label, crossover study. J Asthma
2003;40(5):475-485.
43.
Bushnell DM, Martin ML, Parasuraman B. Electronic versus paper questionnaires: a further
comparison in persons with asthma. J Asthma 2003;40(7):751-762.
44.
Busse W, Koenig SM, Oppenheimer J, Sahn SA, Yancey SW, Reilly D, Edwards LD,
Dorinsky PM. Steroid-sparing effects of fluticasone propionate 100 microg and salmeterol 50
microg administered twice daily in a single product in patients previously controlled with
fluticasone propionate 250 microg administered twice daily. J Allergy Clin Immunol
2003;111(1):57-65.
45.
Buttner C, Lun A, Splettstoesser T, Kunkel G, Renz H. Monoclonal anti-interleukin-5
treatment suppresses eosinophil but not T-cell functions. Eur Respir J 2003;21(5):799-803.
46.
Camargo CA, Jr., Smithline HA, Malice MP, Green SA, Reiss TF. A randomized controlled
trial of intravenous montelukast in acute asthma. Am J Respir Crit Care Med 2003;167(4):528-533.
47.
Camporota L, Corkhill A, Long H, Lordan J, Stanciu L, Tuckwell N, Cross A, Stanford JL,
Rook GA, Holgate ST, Djukanovic R. The effects of Mycobacterium vaccae on allergen-induced
airway responses in atopic asthma. Eur Respir J 2003;21(2):287-293.
48.
Carl JC, Myers TR, Kirchner HL, Kercsmar CM. Comparison of racemic albuterol and
levalbuterol for treatment of acute asthma. J Pediatr 2003;143(6):731-736.
49.
Casale TB, Nelson HS, Kemp J, Parasuraman B, Uryniak T, Liljas B. Budesonide
Turbuhaler delivered once daily improves health-related quality of life and maintains
improvements with a stepped-down dose in adults with mild to moderate asthma. Ann Allergy
Asthma Immunol 2003;90(3):323-330.
50.
Chakir J, Shannon J, Molet S, Fukakusa M, Elias J, Laviolette M, Boulet LP, Hamid Q.
Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGFbeta, IL-11, IL-17, and type I and type III collagen expression. J Allergy Clin Immunol
2003;111(6):1293-1298.
51.
Chaudhuri R, Livingston E, McMahon AD, Thomson L, Borland W, Thomson NC.
Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J
Respir Crit Care Med 2003;168(11):1308-1311.
52.
Chavasse R, Johnson P, Francis J, Balfour-Lynn I, Rosenthal M, Bush A. To clip or not to
clip? Noseclips for spirometry. Eur Respir J 2003;21(5):876-878.
53.
Chetta A, Zanini A, Foresi A, Del Donno M, Castagnaro A, D'Ippolito R, Baraldo S, Testi
R, Saetta M, Olivieri D. Vascular component of airway remodeling in asthma is reduced by high
dose of fluticasone. Am J Respir Crit Care Med 2003;167(5):751-757.
54.
Cirla AM, Cirla PE, Parmiani S, Pecora S. A pre-seasonal birch/hazel sublingual
immunotherapy can improve the outcome of grass pollen injective treatment in bisensitized
individuals. A case-referent, two-year controlled study. Allergol Immunopathol (Madr)
2003;31(1):31-43.
55.
Cooper S, Oborne J, Newton S, Harrison V, Thompson Coon J, Lewis S, Tattersfield A.
Effect of two breathing exercises (Buteyko and pranayama) in asthma: a randomised controlled
trial. Thorax 2003;58(8):674-679.
56.
Corren J, Casale T, Deniz Y, Ashby M. Omalizumab, a recombinant humanized anti-IgE
antibody, reduces asthma-related emergency room visits and hospitalizations in patients with
allergic asthma. J Allergy Clin Immunol 2003;111(1):87-90.
57.
Corren J, Berkowitz R, Murray JJ, Prenner B. Comparison of once-daily mometasone
furoate versus once-daily budesonide in patients with moderate persistent asthma. Int J Clin Pract
2003;57(7):567-572.
58.
Counil FP, Varray A, Matecki S, Beurey A, Marchal P, Voisin M, Prefaut C. Training of
aerobic and anaerobic fitness in children with asthma. J Pediatr 2003;142(2):179-184.
59.
Covar RA, Szefler SJ, Martin RJ, Sundstrom DA, Silkoff PE, Murphy J, Young DA, Spahn
JD. Relations between exhaled nitric oxide and measures of disease activity among children with
mild-to-moderate asthma. J Pediatr 2003;142(5):469-475.
60.
Csonka P, Kaila M, Laippala P, Iso-Mustajarvi M, Vesikari T, Ashorn P. Oral prednisolone
in the acute management of children age 6 to 35 months with viral respiratory infection-induced
lower airway disease: a randomized, placebo-controlled trial. J Pediatr 2003;143(6):725-730.
61.
Currie GP, Fowler SJ, Lipworth BJ. Dose response of inhaled corticosteroids on bronchial
hyperresponsiveness: a meta-analysis. Ann Allergy Asthma Immunol 2003;90(2):194-198.
62.
Currie GP, Lee DK, Haggart K, Bates CE, Lipworth BJ. Effects of montelukast on
surrogate inflammatory markers in corticosteroid-treated patients with asthma. Am J Respir Crit
Care Med 2003;167(9):1232-1238.
63.
Currie GP, Stenback S, Lipworth BJ. Effects of fluticasone vs. fluticasone/salmeterol on
airway calibre and airway hyperresponsiveness in mild persistent asthma. Br J Clin Pharmacol
2003;56(1):11-17.
64.
Currie GP, Lee DK, Dempsey OJ, Fowler SJ, Cowan LM, Lipworth BJ. A proof of concept
study to evaluate putative benefits of montelukast in moderate persistent asthmatics. Br J Clin
Pharmacol 2003;55(6):609-615.
65.
Currie GP, Bates CE, Lee DK, Jackson CM, Lipworth BJ. Effects of fluticasone plus
salmeterol versus twice the dose of fluticasone in asthmatic patients. Eur J Clin Pharmacol
2003;59(1):11-15.
66.
Currie GP, Haggart K, Lee DK, Fowler SJ, Wilson AM, Brannan JD, Anderson SD,
Lipworth BJ. Effects of mediator antagonism on mannitol and adenosine monophosphate
challenges. Clin Exp Allergy 2003;33(6):783-788.
67.
Cylly A, Kara A, Ozdemir T, Ogus C, Gulkesen KH. Effects of oral montelukast on airway
function in acute asthma. Respir Med 2003;97(5):533-536.
68.
Dahlstrom K, Thorsson L, Larsson P, Nikander K. Systemic availability and lung deposition
of budesonide via three different nebulizers in adults. Ann Allergy Asthma Immunol
2003;90(2):226-232.
69.
Datta D, Vitale A, Lahiri B, ZuWallack R. An evaluation of nebulized levalbuterol in stable
COPD. Chest 2003;124(3):844-849.
70.
Davis BE, Reid JK, Cockcroft DW. Formoterol thrice weekly does not result in the
development of tolerance to bronchoprotection. Can Respir J 2003;10(1):23-26.
71.
Davis JM, Parad RB, Michele T, Allred E, Price A, Rosenfeld W. Pulmonary outcome at 1
year corrected age in premature infants treated at birth with recombinant human CuZn superoxide
dismutase. Pediatrics 2003;111(3):469-476.
72.
de Blay F, Fourgaut G, Hedelin G, Vervloet D, Michel FB, Godard P, Charpin D, Pauli G.
Medical Indoor Environment Counselor (MIEC): role in compliance with advice on mite allergen
avoidance and on mite allergen exposure. Allergy 2003;58(1):27-33.
73.
de Kluijver J, Evertse CE, Sont JK, Schrumpf JA, van Zeijl-van der Ham CJ, Dick CR,
Rabe KF, Hiemstra PS, Sterk PJ. Are rhinovirus-induced airway responses in asthma aggravated by
chronic allergen exposure? Am J Respir Crit Care Med 2003;168(10):1174-1180.
74.
de Kluijver J, Grunberg K, Pons D, de Klerk EP, Dick CR, Sterk PJ, Hiemstra PS.
Interleukin-1beta and interleukin-1ra levels in nasal lavages during experimental rhinovirus
infection in asthmatic and non-asthmatic subjects. Clin Exp Allergy 2003;33(10):1415-1418.
75.
Delacourt C, Dutau G, Lefrancois G, Clerson P. Comparison of the efficacy and safety of
nebulized beclometasone dipropionate and budesonide in severe persistent childhood asthma.
Respir Med 2003;97 Suppl B:S27-33.
76.
Delgado A, Chou KJ, Silver EJ, Crain EF. Nebulizers vs metered-dose inhalers with spacers
for bronchodilator therapy to treat wheezing in children aged 2 to 24 months in a pediatric
emergency department. Arch Pediatr Adolesc Med 2003;157(1):76-80.
77.
Devadason SG, Huang T, Walker S, Troedson R, Le Souef PN. Distribution of technetium99m-labelled QVAR delivered using an Autohaler device in children. Eur Respir J
2003;21(6):1007-1011.
78.
Di Rienzo V, Marcucci F, Puccinelli P, Parmiani S, Frati F, Sensi L, Canonica GW,
Passalacqua G. Long-lasting effect of sublingual immunotherapy in children with asthma due to
house dust mite: a 10-year prospective study. Clin Exp Allergy 2003;33(2):206-210.
79.
Doherty GM, Christie SN, Skibinski G, Puddicombe SM, Warke TJ, de Courcey F, Cross
AL, Lyons JD, Ennis M, Shields MD, Heaney LG. Non-bronchoscopic sampling and culture of
bronchial epithelial cells in children. Clin Exp Allergy 2003;33(9):1221-1225.
80.
Donohue JF, Menjoge S, Kesten S. Tolerance to bronchodilating effects of salmeterol in
COPD. Respir Med 2003;97(9):1014-1020.
81.
Drachenberg KJ, Proll S, Urban E, Woroniecki SR. Single-course specific immunotherapy
with mixed pollen allergoids: results of a multi-centre study. Allergol Immunopathol (Madr)
2003;31(2):77-82.
82.
Drblik S, Lapierre G, Thivierge R, Turgeon J, Gaudreault P, Cummins-McManus B, Verdy
I, Haddon J, Lee J, Spier S. Comparative efficacy of terbutaline sulphate delivered by Turbuhaler
dry powder inhaler or pressurised metered dose inhaler with Nebuhaler spacer in children during an
acute asthmatic episode. Arch Dis Child 2003;88(4):319-323.
83.
Dubus JC, Guillot C, Badier M. Electrostatic charge on spacer devices and salbutamol
response in young children. Int J Pharm 2003;261(1-2):159-164.
84.
Ducharme FM, Chabot G, Polychronakos C, Glorieux F, Mazer B. Safety profile of
frequent short courses of oral glucocorticoids in acute pediatric asthma: impact on bone metabolism,
bone density, and adrenal function. Pediatrics 2003;111(2):376-383.
85.
Ducharme FM. Inhaled glucocorticoids versus leukotriene receptor antagonists as single
agent asthma treatment: systematic review of current evidence. Bmj 2003;326(7390):621.
86.
Dunstan JA, Mori TA, Barden A, Beilin LJ, Taylor AL, Holt PG, Prescott SL. Maternal fish
oil supplementation in pregnancy reduces interleukin-13 levels in cord blood of infants at high risk
of atopy. Clin Exp Allergy 2003;33(4):442-448.
87.
Eddleston J, Christiansen SC, Jenkins GR, Koziol JA, Zuraw BL. Bradykinin increases the
in vivo expression of the CXC chemokine receptors CXCR1 and CXCR2 in patients with allergic
rhinitis. J Allergy Clin Immunol 2003;111(1):106-112.
88.
Ederle K. Improved control of asthma symptoms with a reduced dose of HFA-BDP
extrafine aerosol: an open-label, randomised study. Eur Rev Med Pharmacol Sci 2003;7(2):45-55.
89.
El-Sharif NA, Nemery B, Barghuthy F, Mortaja S, Qasrawi R, Abdeen Z. Geographical
variations of asthma and asthma symptoms among schoolchildren aged 5 to 8 years and 12 to 15
years in Palestine: the International Study of Asthma and Allergies in Childhood (ISAAC). Ann
Allergy Asthma Immunol 2003;90(1):63-71.
90.
ElHalawani SM, Ly NT, Mahon RT, Amundson DE. Exhaled nitric oxide as a predictor of
exercise-induced bronchoconstriction. Chest 2003;124(2):639-643.
91.
Elster A, Jarosik J, VanGeest J, Fleming M. Racial and ethnic disparities in health care for
adolescents: a systematic review of the literature. Arch Pediatr Adolesc Med 2003;157(9):867-874.
92.
Filippelli M, Duranti R, Gigliotti F, Bianchi R, Grazzini M, Stendardi L, Scano G. Overall
contribution of chest wall hyperinflation to breathlessness in asthma. Chest 2003;124(6):2164-2170.
93.
Finn A, Gross G, van Bavel J, Lee T, Windom H, Everhard F, Fowler-Taylor A, Liu J,
Gupta N. Omalizumab improves asthma-related quality of life in patients with severe allergic
asthma. J Allergy Clin Immunol 2003;111(2):278-284.
94.
Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS. Eosinophil's role remains
uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir
Crit Care Med 2003;167(2):199-204.
95.
Flood-Page P, Menzies-Gow A, Phipps S, Ying S, Wangoo A, Ludwig MS, Barnes N,
Robinson D, Kay AB. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial
subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 2003;112(7):1029-1036.
96.
Fogarty A, Lewis SA, Scrivener SL, Antoniak M, Pacey S, Pringle M, Britton J. Oral
magnesium and vitamin C supplements in asthma: a parallel group randomized placebo-controlled
trial. Clin Exp Allergy 2003;33(10):1355-1359.
97.
Forrest CB, Shipman SA, Dougherty D, Miller MR. Outcomes research in pediatric
settings: recent trends and future directions. Pediatrics 2003;111(1):171-178.
98.
Frezza G, Terra-Filho J, Martinez JA, Vianna EO. Rapid effect of inhaled steroids on
nocturnal worsening of asthma. Thorax 2003;58(7):632-633.
99.
Fukuoka T, Miyake S, Umino T, Inase N, Tojo N, Yoshizawa Y. The effect of seratrodast
on eosinophil cationic protein and symptoms in asthmatics. J Asthma 2003;40(3):257-264.
100. Fukushima C, Matsuse H, Tomari S, Obase Y, Miyazaki Y, Shimoda T, Kohno S. Oral
candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and
beclomethasone. Ann Allergy Asthma Immunol 2003;90(6):646-651.
101. Gauvreau GM, Becker AB, Boulet LP, Chakir J, Fick RB, Greene WL, Killian KJ, O'Byrne
P M, Reid JK, Cockcroft DW. The effects of an anti-CD11a mAb, efalizumab, on allergen-induced
airway responses and airway inflammation in subjects with atopic asthma. J Allergy Clin Immunol
2003;112(2):331-338.
102. Gawchik SM, Saccar CL, Noonan M, Reasner DS, DeGraw SS. The safety and efficacy of
nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in
pediatric patients. J Allergy Clin Immunol 1999;103(4):615-621.
103. Gessner C, Stenglein S, Brautigam M, Muller A, Schauer J. [Miflonide/Foradil via
Aerolizer compared with other anti-inflammatory and anti-obstructive therapeutic regimens].
Pneumologie 2003;57(3):137-143.
104. Giannini D, Di Franco A, Tonelli M, Bartoli ML, Carnevali S, Cianchetti S, Bacci E, Dente
FL, Vagaggini B, Paggiaro PL. Fifty microg b.i.d. of inhaled fluticasone propionate (FP) are
effective in stable asthmatics previously treated with a higher dose of FP. Respir Med
2003;97(5):463-467.
105. Gibson PG, Ram FS, Powell H. Asthma education. Respir Med 2003;97(9):1036-1044.
106. Giroux M, Ferrieres J. Creatininuria in asthmatic children treated with a combination of
glucocorticoid and beta-agonist. J Asthma 2003;40(1):41-48.
107. Glasgow NJ, Ponsonby AL, Yates R, Beilby J, Dugdale P. Proactive asthma care in
childhood: general practice based randomised controlled trial. Bmj 2003;327(7416):659.
108. Gong H, Jr., Linn WS, Sioutas C, Terrell SL, Clark KW, Anderson KR, Terrell LL.
Controlled exposures of healthy and asthmatic volunteers to concentrated ambient fine particles in
Los Angeles. Inhal Toxicol 2003;15(4):305-325.
109. Gordon JR, Swystun VA, Li F, Zhang X, Davis BE, Hull P, Cockcroft DW. Regular
salbutamol use increases CXCL8 responses in asthma: relationship to the eosinophil response. Eur
Respir J 2003;22(1):118-126.
110. Gorelick MH, Scribano PV, Stevens MW, Schultz TR. Construct validity and
responsiveness of the Child Health Questionnaire in children with acute asthma. Ann Allergy
Asthma Immunol 2003;90(6):622-628.
111. Gross G, Cohen RM, Guy H. Efficacy response of inhaled HFA-albuterol delivered via the
breath-actuated Autohaler inhalation device is comparable to dose in patients with asthma. J
Asthma 2003;40(5):487-495.
112. Grzelewska-Rzymowska I, Kroczynska-Bednarek J, Zarkovic J. Comparison of the efficacy
and safety of high doses of beclometasone dipropionate suspension for nebulization and
beclometasone dipropionate via a metered-dose inhaler in steroid-dependent adults with moderate
to severe asthma. Respir Med 2003;97 Suppl B:S21-26.
113. Guevara JP, Wolf FM, Grum CM, Clark NM. Effects of educational interventions for self
management of asthma in children and adolescents: systematic review and meta-analysis. Bmj
2003;326(7402):1308-1309.
114. Gunawardena KA, Crame N, Mertz B, Shams N. Safety of unoprostone isopropyl 0.15%
ophthalmic solution in patients with mild to moderate asthma. Ophthalmologica 2003;217(2):129136.
115. Gupta P, Sachdev HP. Safety of oral use of nimesulide in children: systematic review of
randomized controlled trials. Indian Pediatr 2003;40(6):518-531.
116. Gyllfors P, Bochenek G, Overholt J, Drupka D, Kumlin M, Sheller J, Nizankowska E,
Isakson PC, Mejza F, Lefkowith JB, Dahlen SE, Szczeklik A, Murray JJ, Dahlen B. Biochemical
and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2selective analgetic drug celecoxib. J Allergy Clin Immunol 2003;111(5):1116-1121.
117. Hahtola PA, Hahtola KH. Asthma in light of patient documents. A factor analytic study.
Ann Acad Med Singapore 2003;32(3):392-402.
118. Halken S, Host A, Niklassen U, Hansen LG, Nielsen F, Pedersen S, Osterballe O, Veggerby
C, Poulsen LK. Effect of mattress and pillow encasings on children with asthma and house dust
mite allergy. J Allergy Clin Immunol 2003;111(1):169-176.
119. Hall J, Penrose A, Tomlin A, Reid J. Differential prescribing of inhaled corticosteroids in
New Zealand general practice. N Z Med J 2003;116(1180):U563.
120. Hansel TT, Kharitonov SA, Donnelly LE, Erin EM, Currie MG, Moore WM, Manning PT,
Recker DP, Barnes PJ. A selective inhibitor of inducible nitric oxide synthase inhibits exhaled
breath nitric oxide in healthy volunteers and asthmatics. Faseb J 2003;17(10):1298-1300.
121. Harrison TW, Tattersfield AE. Plasma concentrations of fluticasone propionate and
budesonide following inhalation from dry powder inhalers by healthy and asthmatic subjects.
Thorax 2003;58(3):258-260.
122. Hasani A, Toms N, O'Connor J, Dilworth JP, Agnew JE. Effect of salmeterol xinafoate on
lung mucociliary clearance in patients with asthma. Respir Med 2003;97(6):667-671.
123. Hawkins G, McMahon AD, Twaddle S, Wood SF, Ford I, Thomson NC. Stepping down
inhaled corticosteroids in asthma: randomised controlled trial. Bmj 2003;326(7399):1115.
124. Heaney LG, Conway E, Kelly C, Johnston BT, English C, Stevenson M, Gamble J.
Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol. Thorax
2003;58(7):561-566.
125. Henry RR, Mudaliar SR, Howland WC, 3rd, Chu N, Kim D, An B, Reinhardt RR. Inhaled
insulin using the AERx Insulin Diabetes Management System in healthy and asthmatic subjects.
Diabetes Care 2003;26(3):764-769.
126. Ho AM, Lee A, Karmakar MK, Dion PW, Chung DC, Contardi LH. Heliox vs air-oxygen
mixtures for the treatment of patients with acute asthma: a systematic overview. Chest
2003;123(3):882-890.
127. Hofmann D, Hecker M, Volp A. Efficacy of dry extract of ivy leaves in children with
bronchial asthma--a review of randomized controlled trials. Phytomedicine 2003;10(2-3):213-220.
128. Holcroft CA, Eisen EA, Sama SR, Wegman DH. Measurement characteristics of peak
expiratory flow. Chest 2003;124(2):501-510.
129. Holzer K, Anderson SD, Chan HK, Douglass J. Mannitol as a challenge test to identify
exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med
2003;167(4):534-537.
130. Hsu CH, Yu MC, Lee CH, Lee TC, Yang SY. High eosinophil cationic protein level in
asthmatic patients with "heat" Zheng. Am J Chin Med 2003;31(2):277-283.
131. Huang CJ, Wang CH, Liu WT, Yang MC, Lin HC, Yu CT, Shiao CJ, Tan CC, Yang CK,
Kuo HP. Zafirlukast improves pulmonary function in patients with moderate persistent asthma
receiving regular inhaled steroids: a prospective randomized control study. Chang Gung Med J
2003;26(8):554-560.
132. Hughes R, Goldkorn A, Masoli M, Weatherall M, Burgess C, Beasley R. Use of isotonic
nebulised magnesium sulphate as an adjuvant to salbutamol in treatment of severe asthma in adults:
randomised placebo-controlled trial. Lancet 2003;361(9375):2114-2117.
133. Huss K, Winkelstein M, Nanda J, Naumann PL, Sloand ED, Huss RW. Computer game for
inner-city children does not improve asthma outcomes. J Pediatr Health Care 2003;17(2):72-78.
134. Ind PW, Dal Negro R, Colman NC, Fletcher CP, Browning D, James MH. Addition of
salmeterol to fluticasone propionate treatment in moderate-to-severe asthma. Respir Med
2003;97(5):555-562.
135. Janson SL, Fahy JV, Covington JK, Paul SM, Gold WM, Boushey HA. Effects of
individual self-management education on clinical, biological, and adherence outcomes in asthma.
Am J Med 2003;115(8):620-626.
136. Jian Z, Nakayama J, Noguchi E, Shibasaki M, Arinami T. No evidence for association
between the -112G/A polymorphism of UGRP1 and childhood atopic asthma. Clin Exp Allergy
2003;33(7):902-904.
137. Jiang SP, Liang RY, Zeng ZY, Liu QL, Liang YK, Li JG. Effects of antireflux treatment on
bronchial hyper-responsiveness and lung function in asthmatic patients with gastroesophageal
reflux disease. World J Gastroenterol 2003;9(5):1123-1125.
138. Juergens UR, Dethlefsen U, Steinkamp G, Gillissen A, Repges R, Vetter H. Antiinflammatory activity of 1.8-cineol (eucalyptol) in bronchial asthma: a double-blind placebocontrolled trial. Respir Med 2003;97(3):250-256.
139. Kamps AW, Brand PL, Kimpen JL, Maille AR, Overgoor-van de Groes AW, van
Helsdingen-Peek LC, Roorda RJ. Outpatient management of childhood asthma by paediatrician or
asthma nurse: randomised controlled study with one year follow up. Thorax 2003;58(11):968-973.
140. Katial RK. Cockroach allergy. Immunol Allergy Clin North Am 2003;23(3):483-499.
141. Khayyal MT, el-Ghazaly MA, el-Khatib AS, Hatem AM, de Vries PJ, el-Shafei S, Khattab
MM. A clinical pharmacological study of the potential beneficial effects of a propolis food product
as an adjuvant in asthmatic patients. Fundam Clin Pharmacol 2003;17(1):93-102.
142. Khoshbaten M. Gastro-esophageal reflux disease in northwestern Tabriz, Iran. Indian J
Gastroenterol 2003;22(4):138-139.
143. Kips JC, O'Connor BJ, Langley SJ, Woodcock A, Kerstjens HA, Postma DS, Danzig M,
Cuss F, Pauwels RA. Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in
severe persistent asthma: a pilot study. Am J Respir Crit Care Med 2003;167(12):1655-1659.
144. Koehle M, Lloyd-Smith R, McKenzie D, Taunton J. Asthma and recreational SCUBA
diving: a systematic review. Sports Med 2003;33(2):109-116.
145. Konstas AG, Papapanos P, Tersis I, Houliara D, Stewart WC. Twenty-four-hour diurnal
curve comparison of commercially available latanoprost 0.005% versus the timolol and
dorzolamide fixed combination. Ophthalmology 2003;110(7):1357-1360.
146. Koskela HO, Hyvarinen L, Brannan JD, Chan HK, Anderson SD. Responsiveness to three
bronchial provocation tests in patients with asthma. Chest 2003;124(6):2171-2177.
147. Kraft M, Martin RJ, Lazarus SC, Fahy JV, Boushey HA, Lemanske RF, Jr., Szefler SJ.
Airway tissue mast cells in persistent asthma: predictor of treatment failure when patients
discontinue inhaled corticosteroids. Chest 2003;124(1):42-50.
148. Krishna S, Francisco BD, Balas EA, Konig P, Graff GR, Madsen RW. Internet-enabled
interactive multimedia asthma education program: a randomized trial. Pediatrics 2003;111(3):503510.
149. Kumaratne M, Gunawardane G. Addition of ipratropium to nebulized albuterol in children
with acute asthma presenting to a pediatric office. Clin Pediatr (Phila) 2003;42(2):127-132.
150. Kuna P, Joubert JR, Greefhorst LA, Magnussen H. A randomized, double-blind, doubledummy, parallel-group, multicenter, dose-reduction trial of the minimal effective doses of
budesonide and fluticasone dry-powder inhalers in adults with mild to moderate asthma. Clin Ther
2003;25(8):2182-2197.
151. Kyngas H. Patient education: perspective of adolescents with a chronic disease. J Clin Nurs
2003;12(5):744-751.
152. Lalloo UG, Malolepszy J, Kozma D, Krofta K, Ankerst J, Johansen B, Thomson NC.
Budesonide and formoterol in a single inhaler improves asthma control compared with increasing
the dose of corticosteroid in adults with mild-to-moderate asthma. Chest 2003;123(5):1480-1487.
153. Lambiase A, Bonini S, Rasi G, Coassin M, Bruscolini A. Montelukast, a leukotriene
receptor antagonist, in vernal keratoconjunctivitis associated with asthma. Arch Ophthalmol
2003;121(5):615-620.
154. Landstra AM, Boezen HM, Postma DS, van Aalderen WM. Effect of intravenous
hydrocortisone on nocturnal airflow limitation in childhood asthma. Eur Respir J 2003;21(4):627632.
155. Lanier BQ, Corren J, Lumry W, Liu J, Fowler-Taylor A, Gupta N. Omalizumab is effective
in the long-term control of severe allergic asthma. Ann Allergy Asthma Immunol 2003;91(2):154159.
156. Larsen BB, Nielsen LP, Engelstatter R, Steinijans V, Dahl R. Effect of ciclesonide on
allergen challenge in subjects with bronchial asthma. Allergy 2003;58(3):207-212.
157. Lee DK, Bates CE, Currie GP, Lipworth BJ. Comparative in vivo bioactivity of modern H1antihistamines on AMP challenge in atopic asthma. J Allergy Clin Immunol 2003;111(2):337-341.
158. Leone FT, Fish JE, Szefler SJ, West SL. Systematic review of the evidence regarding
potential complications of inhaled corticosteroid use in asthma: collaboration of American College
of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American
College of Allergy, Asthma, and Immunology. Chest 2003;124(6):2329-2340.
159. Leuppi JD, Salzberg M, Meyer L, Bucher SE, Nief M, Brutsche MH, Tamm M. An
individualized, adjustable maintenance regimen of budesonide/formoterol provides effective
asthma symptom control at a lower overall dose than fixed dosing. Swiss Med Wkly 2003;133(2122):302-309.
160. Linden A, Hansson L, Andersson A, Palmqvist M, Arvidsson P, Lofdahl CG, Larsson P,
Lotvall J. Bronchodilation by an inhaled VPAC(2) receptor agonist in patients with stable asthma.
Thorax 2003;58(3):217-221.
161. Lindqvist A, Karjalainen EM, Laitinen LA, Kava T, Altraja A, Pulkkinen M, Halme M,
Laitinen A. Salmeterol resolves airway obstruction but does not possess anti-eosinophil efficacy in
newly diagnosed asthma: a randomized, double-blind, parallel group biopsy study comparing the
effects of salmeterol, fluticasone propionate, and disodium cromoglycate. J Allergy Clin Immunol
2003;112(1):23-28.
162. Liu AH, Murphy JR. Hygiene hypothesis: fact or fiction? J Allergy Clin Immunol
2003;111(3):471-478.
163. Lotvall J, Palmqvist M, Arvidsson P, Maloney A, Ventresca GP, Ward J. The therapeutic
ratio of R-albuterol is comparable with that of RS-albuterol in asthmatic patients. J Allergy Clin
Immunol 2001;108(5):726-731.
164. Lu LR, Peat JK, Sullivan CE. Snoring in preschool children: prevalence and association
with nocturnal cough and asthma. Chest 2003;124(2):587-593.
165. Lyttle B, Gilles J, Panov M, Emeryk A, Wixon C. Fluticasone propionate 100 microg bid
using a non-CFC propellant, HFA 134a, in asthmatic children. Can Respir J 2003;10(2):103-109.
166. Malm H, Martikainen J, Klaukka T, Neuvonen PJ. Prescription drugs during pregnancy and
lactation--a Finnish register-based study. Eur J Clin Pharmacol 2003;59(2):127-133.
167. Malmberg LP, Pelkonen AS, Haahtela T, Turpeinen M. Exhaled nitric oxide rather than
lung function distinguishes preschool children with probable asthma. Thorax 2003;58(6):494-499.
168. Mann M, Chowdhury B, Sullivan E, Nicklas R, Anthracite R, Meyer RJ. Serious asthma
exacerbations in asthmatics treated with high-dose formoterol. Chest 2003;124(1):70-74.
169. Marogna M, Massolo A. Sublingual immunotherapy in the context of a clinical practice
improvement program in the allergological setting: results of a long-term observational study.
Allerg Immunol (Paris) 2003;35(4):133-140.
170. Martinat Y, Desfougeres JL. [Fixed-dose fluticasone-salmeterol combination: at least
effective and better tolerated than open-dose combinations]. Rev Pneumol Clin 2003;59(3):139-148.
171. Matheson NJ, Symmonds-Abrahams M, Sheikh A, Shepperd S, Harnden A. Neuraminidase
inhibitors for preventing and treating influenza in children. Cochrane Database Syst Rev
2003(3):CD002744.
172. McColl E, Eccles MP, Rousseau NS, Steen IN, Parkin DW, Grimshaw JM. From the
generic to the condition-specific?: Instrument order effects in Quality of Life Assessment. Med
Care 2003;41(7):777-790.
173. MeGhan SL, Wong E, Jhangri GS, Wells HM, Michaelchuk DR, Boechler VL, Befus AD,
Hessel PA. Evaluation of an education program for elementary school children with asthma. J
Asthma 2003;40(5):523-533.
174. Melo RE, Sole D, Naspitz CK. Exercise-induced bronchoconstriction in children:
montelukast attenuates the immediate-phase and late-phase responses. J Allergy Clin Immunol
2003;111(2):301-307.
175. Mendes ES, Pereira A, Danta I, Duncan RC, Wanner A. Comparative bronchial
vasoconstrictive efficacy of inhaled glucocorticosteroids. Eur Respir J 2003;21(6):989-993.
176. Menzies-Gow A, Flood-Page P, Sehmi R, Burman J, Hamid Q, Robinson DS, Kay AB,
Denburg J. Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest
and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics. J Allergy Clin
Immunol 2003;111(4):714-719.
177. Meyer KA, Arduino JM, Santanello NC, Knorr BA, Bisgaard H. Response to montelukast
among subgroups of children aged 2 to 14 years with asthma. J Allergy Clin Immunol
2003;111(4):757-762.
178. Mickleborough TD, Murray RL, Ionescu AA, Lindley MR. Fish oil supplementation
reduces severity of exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care
Med 2003;168(10):1181-1189.
179. Mihrshahi S, Peat JK, Marks GB, Mellis CM, Tovey ER, Webb K, Britton WJ, Leeder SR.
Eighteen-month outcomes of house dust mite avoidance and dietary fatty acid modification in the
Childhood Asthma Prevention Study (CAPS). J Allergy Clin Immunol 2003;111(1):162-168.
180. Mihrshahi S, Marks GB, Criss S, Tovey ER, Vanlaar CH, Peat JK. Effectiveness of an
intervention to reduce house dust mite allergen levels in children's beds. Allergy 2003;58(8):784789.
181. Milgrom H, Skoner DP, Bensch G, Kim KT, Claus R, Baumgartner RA. Low-dose
levalbuterol in children with asthma: safety and efficacy in comparison with placebo and racemic
albuterol. J Allergy Clin Immunol 2001;108(6):938-945.
182. Millard MW, Johnson PT, McEwen M, Neatherlin J, Lawrence G, Kennerly DK, Bokovoy
JL. A randomized controlled trial using the school for anti-inflammatory therapy in asthma. J
Asthma 2003;40(7):769-776.
183. Miller RL, Cheng M, DiMango EA, Geromanos K, Rothman PB. T-cell responses and
hypersensitivity to influenza and egg antigens among adults with asthma immunized with the
influenza vaccine. J Allergy Clin Immunol 2003;112(3):606-608.
184. Minoguchi H, Minoguchi K, Tanaka A, Matsuo H, Kihara N, Adachi M. Cough receptor
sensitivity to capsaicin does not change after allergen bronchoprovocation in allergic asthma.
Thorax 2003;58(1):19-22.
185. Mitchell C, Jenkins C, Scicchitano R, Rubinfeld A, Kottakis J. Formoterol (Foradil) and
medium-high doses of inhaled corticosteroids are more effective than high doses of corticosteroids
in moderate-to-severe asthma. Pulm Pharmacol Ther 2003;16(5):299-306.
186. Moller M, Fritsche D, Rivera D, Libertus H. Improvement of asthma therapy by a novel
budesonide multidose dry powder inhaler. Arzneimittelforschung 2003;53(8):562-567.
187. Monroe KW, Nichols MH, King WD, Tucker K, Tomlinson R. Comparison of two forms of
albuterol for treatment of acute bronchospasm in pediatric patients. South Med J 2003;96(5):440444.
188. Murphy KR, Fitzpatrick S, Cruz-Rivera M, Miller CJ, Parasuraman B. Effects of
budesonide inhalation suspension compared with cromolyn sodium nebulizer solution on health
status and caregiver quality of life in childhood asthma. Pediatrics 2003;112(3 Pt 1):e212-219.
189. Naidu Sjosward K, Josefsson M, Ahlner J, Andersson RG, Schmekel B. Metabolism of
salbutamol differs between asthmatic patients and healthy volunteers. Pharmacol Toxicol
2003;92(1):27-32.
190. Nakanishi AK, Klasner AK, Rubin BK. A randomized controlled trial of inhaled flunisolide
in the management of acute asthma in children. Chest 2003;124(3):790-794.
191. Nakano Y, Morita S, Kawamoto A, Naito T, Enomoto N, Suda T, Chida K, Nakamura H.
Efficacy of a consensus protocol therapy in adults with acute, severe asthma. Ann Allergy Asthma
Immunol 2003;90(3):331-337.
192. Nathan RA, Dorinsky P, Rosenzweig JR, Shah T, Edin H, Prillaman B. Improved ability to
perform strenuous activities after treatment with fluticasone propionate/salmeterol combination in
patients with persistent asthma. J Asthma 2003;40(7):815-822.
193. Nelson HS, Wolfe JD, Gross G, Greos LS, Baitinger L, Scott C, Dorinsky P. Efficacy and
safety of fluticasone propionate 44 microg/salmeterol 21 microg administered in a
hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment. Ann Allergy
Asthma Immunol 2003;91(3):263-269.
194. Newhouse MT, Patel P, Parry-Billings M. Protection against methacholine-induced
bronchospasm: salbutamol pMDI versus Clickhaler DPI. Eur Respir J 2003;21(5):816-820.
195. Nieto L, de Diego A, Perpina M, Compte L, Garrigues V, Martinez E, Ponce J. Cough
reflex testing with inhaled capsaicin in the study of chronic cough. Respir Med 2003;97(4):393-400.
196. Niitsuma T, Okita M, Sakurai K, Morita S, Tsuyuguchi M, Matsumura Y, Hayashi T,
Koshishi T, Oka K, Homma M. Adrenal function as assessed by low-dose adrenocorticotropin
hormone test before and after switching from inhaled beclomethasone dipropionate to inhaled
fluticasone propionate. J Asthma 2003;40(5):515-522.
197. Nikander K, Arheden L, Denyer J, Cobos N. Parents' adherence with nebulizer treatment of
their children when using an adaptive aerosol delivery (AAD) system. J Aerosol Med
2003;16(3):273-281.
198. Nilsson L, Kjellman NI, Bjorksten B. Allergic disease at the age of 7 years after pertussis
vaccination in infancy: results from the follow-up of a randomized controlled trial of 3 vaccines.
Arch Pediatr Adolesc Med 2003;157(12):1184-1189.
199. Noga O, Hanf G, Kunkel G. Immunological and clinical changes in allergic asthmatics
following treatment with omalizumab. Int Arch Allergy Immunol 2003;131(1):46-52.
200. O'Sullivan S, Akveld M, Burke CM, Poulter LW. Effect of the addition of montelukast to
inhaled fluticasone propionate on airway inflammation. Am J Respir Crit Care Med
2003;167(5):745-750.
201. Obase Y, Shimoda T, Kawano T, Saeki S, Tomari SY, Mitsuta-Izaki K, Matsuse H,
Kinoshita M, Kohno S. Polymorphisms in the CYP1A2 gene and theophylline metabolism in
patients with asthma. Clin Pharmacol Ther 2003;73(5):468-474.
202. Ogawa H. [Otitis media with effusion: treatment by autoinflammation using a balloon].
Nippon Jibiinkoka Gakkai Kaiho 2003;106(6):685-691.
203. Onyirimba F, Apter A, Reisine S, Litt M, McCusker C, Connors M, ZuWallack R. Direct
clinician-to-patient feedback discussion of inhaled steroid use: its effect on adherence. Ann Allergy
Asthma Immunol 2003;90(4):411-415.
204. Opiekun RE, Smeets M, Sulewski M, Rogers R, Prasad N, Vedula U, Dalton P. Assessment
of ocular and nasal irritation in asthmatics resulting from fragrance exposure. Clin Exp Allergy
2003;33(9):1256-1265.
205. Osipova GL. [Multicomponent vaccine VP-4 in the therapy of allergic diseases]. Zh
Mikrobiol Epidemiol Immunobiol 2003(1):36-42.
206. Ozcan M, Ortapamuk H, Naldoken S, Olcay I, Ozcan KM, Tuncel U. Pulmonary aspiration
of nasal secretions in patients with chronic sinusitis and asthma. Arch Otolaryngol Head Neck Surg
2003;129(9):1006-1009.
207. Paganin F, Poubeau P, Yvin JL, Arvin-Berod C. [The effectiveness of leukotriene
antagonists in the treatment of aspirin-intolerant asthmatic patients]. Presse Med 2003;32(21):978984.
208. Palczynski C, Walusiak J, Krakowiak A, Szymczak W, Wittczak T, Ruta U, Gorski P.
Nasal lavage fluid examination in diagnostics of occupational allergy to chloramine. Int J Occup
Med Environ Health 2003;16(3):231-240.
209. Pancu D, LaFlamme M, Evans E, Reed J. Levalbuterol is as effective as racemic albuterol
in lowering serum potassium. J Emerg Med 2003;25(1):13-16.
210. Parker EA, Israel BA, Williams M, Brakefield-Caldwell W, Lewis TC, Robins T, Ramirez
E, Rowe Z, Keeler G. Community action against asthma: examining the partnership process of a
community-based participatory research project. J Gen Intern Med 2003;18(7):558-567.
211. Patel KK, Veenstra DL, Patrick DL. A review of selected patient-generated outcome
measures and their application in clinical trials. Value Health 2003;6(5):595-603.
212. Pauwels RA, Pedersen S, Busse WW, Tan WC, Chen YZ, Ohlsson SV, Ullman A, Lamm
CJ, O'Byrne PM. Early intervention with budesonide in mild persistent asthma: a randomised,
double-blind trial. Lancet 2003;361(9363):1071-1076.
213. Peiris JS, Tang WH, Chan KH, Khong PL, Guan Y, Lau YL, Chiu SS. Children with
respiratory disease associated with metapneumovirus in Hong Kong. Emerg Infect Dis
2003;9(6):628-633.
214. Peterson-Sweeney K, McMullen A, Yoos HL, Kitzman H. Parental perceptions of their
child's asthma: management and medication use. J Pediatr Health Care 2003;17(3):118-125.
215. Phipatanakul W, Greene C, Downes SJ, Cronin B, Eller TJ, Schneider LC, Irani AM.
Montelukast improves asthma control in asthmatic children maintained on inhaled corticosteroids.
Ann Allergy Asthma Immunol 2003;91(1):49-54.
216. Pinnock H, Bawden R, Proctor S, Wolfe S, Scullion J, Price D, Sheikh A. Accessibility,
acceptability, and effectiveness in primary care of routine telephone review of asthma: pragmatic,
randomised controlled trial. Bmj 2003;326(7387):477-479.
217. Pleskow W, LaForce CF, Yegen U, Matos D, Della Cioppa G. Formoterol delivered via the
dry powder Aerolizer inhaler versus albuterol MDI and placebo in mild-to-moderate asthma: a
randomized, double-blind, double-dummy trial. J Asthma 2003;40(5):505-514.
218. Polosa R, Li Gotti F, Mangano G, Mastruzzo C, Pistorio MP, Crimi N. Monitoring of
seasonal variability in bronchial hyper-responsiveness and sputum cell counts in non-asthmatic
subjects with rhinitis and effect of specific immunotherapy. Clin Exp Allergy 2003;33(7):873-881.
219. Powell H, Gibson PG. Inhaled corticosteroid doses in asthma: an evidence-based approach.
Med J Aust 2003;178(5):223-225.
220. Price D, Thomas M, Mitchell G, Niziol C, Featherstone R. Improvement of asthma control
with a breath-actuated pressurised metred dose inhaler (BAI): a prescribing claims study of 5556
patients using a traditional pressurised metred dose inhaler (MDI) or a breath-actuated device.
Respir Med 2003;97(1):12-19.
221. Price DB, Hernandez D, Magyar P, Fiterman J, Beeh KM, James IG, Konstantopoulos S,
Rojas R, van Noord JA, Pons M, Gilles L, Leff JA. Randomised controlled trial of montelukast
plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma.
Thorax 2003;58(3):211-216.
222. Purucker ME, Rosebraugh CJ, Zhou F, Meyer RJ. Inhaled fluticasone propionate by diskus
in the treatment of asthma: a comparison of the efficacy of the same nominal dose given either once
or twice a day. Chest 2003;124(4):1584-1593.
223. Put C, van den Bergh O, Lemaigre V, Demedts M, Verleden G. Evaluation of an
individualised asthma programme directed at behavioural change. Eur Respir J 2003;21(1):109-115.
224. Ram FS, Holloway EA, Jones PW. Breathing retraining for asthma. Respir Med
2003;97(5):501-507.
225. Reid DW, Ward C, Wang N, Zheng L, Bish R, Orsida B, Walters EH. Possible antiinflammatory effect of salmeterol against interleukin-8 and neutrophil activation in asthma in vivo.
Eur Respir J 2003;21(6):994-999.
226. Ricciardolo FL, Timmers MC, Sont JK, Folkerts G, Sterk PJ. Effect of bradykinin on
allergen induced increase in exhaled nitric oxide in asthma. Thorax 2003;58(10):840-845.
227. Ricciardolo FL, Di Stefano A, van Krieken JH, Sont JK, van Schadewijk A, Rabe KF,
Donner CF, Hiemstra PS, Sterk PJ, Mauad T. Proliferation and inflammation in bronchial
epithelium after allergen in atopic asthmatics. Clin Exp Allergy 2003;33(7):905-911.
228. Riccioni G, Vecchia RD, D'Orazio N, Sensi S, Guagnano MT. Comparison of montelukast
and budesonide on bronchial reactivity in subjects with mild-moderate persistent asthma. Pulm
Pharmacol Ther 2003;16(2):111-114.
229. Rieschke P, LaFleur BJ, Janicki PK. Effects of EDTA- and sulfite-containing formulations
of propofol on respiratory system resistance after tracheal intubation in smokers. Anesthesiology
2003;98(2):323-328.
230. Riffelmann FW, Droste G, Lauter H, Kohler D. [Montelukast-free interval before
inhalational bronchial allergen provocation]. Pneumologie 2003;57(8):429-432.
231. Ringdal N, Eliraz A, Pruzinec R, Weber HH, Mulder PG, Akveld M, Bateman ED. The
salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in
asthma. Respir Med 2003;97(3):234-241.
232. Ritz T, Dahme B, Roth WT. Behavioral interventions in asthma: biofeedback techniques. J
Psychosom Res 2004;56(6):711-720.
233. Roberts G, Newsom D, Gomez K, Raffles A, Saglani S, Begent J, Lachman P, Sloper K,
Buchdahl R, Habel A. Intravenous salbutamol bolus compared with an aminophylline infusion in
children with severe asthma: a randomised controlled trial. Thorax 2003;58(4):306-310.
234. Rodrigo GJ, Rodrigo C. Triple inhaled drug protocol for the treatment of acute severe
asthma. Chest 2003;123(6):1908-1915.
235. Rodrigo GJ, Rodrigo C, Pollack CV, Rowe B. Use of helium-oxygen mixtures in the
treatment of acute asthma: a systematic review. Chest 2003;123(3):891-896.
236. Rodrigo GJ, Rodriquez Verde M, Peregalli V, Rodrigo C. Effects of short-term 28% and
100% oxygen on PaCO2 and peak expiratory flow rate in acute asthma: a randomized trial. Chest
2003;124(4):1312-1317.
237. Rosenhall L, Elvstrand A, Tilling B, Vinge I, Jemsby P, Stahl E, Jerre F, Bergqvist PB.
One-year safety and efficacy of budesonide/formoterol in a single inhaler (Symbicort Turbuhaler)
for the treatment of asthma. Respir Med 2003;97(6):702-708.
238. Rosenhall L, Borg S, Andersson F, Ericsson K. Budesonide/formoterol in a single inhaler
(Symbicort) reduces healthcare costs compared with separate inhalers in the treatment of asthma
over 12 months. Int J Clin Pract 2003;57(8):662-667.
239. Rosenwasser LJ, Busse WW, Lizambri RG, Olejnik TA, Totoritis MC. Allergic asthma and
an anti-CD23 mAb (IDEC-152): results of a phase I, single-dose, dose-escalating clinical trial. J
Allergy Clin Immunol 2003;112(3):563-570.
240. Rotteveel J, Potkamp J, Holl H, Delemarre-Van de Waal HA. Growth during early
childhood in asthmatic children: relation to inhalation steroid dose and clinical severity score.
Horm Res 2003;59(5):234-238.
241. Roussos A, Koursarakos P, Patsopoulos D, Gerogianni I, Philippou N. Increased prevalence
of irritable bowel syndrome in patients with bronchial asthma. Respir Med 2003;97(1):75-79.
242. Roux C, Kolta S, Desfougeres JL, Minini P, Bidat E. Long-term safety of fluticasone
propionate and nedocromil sodium on bone in children with asthma. Pediatrics 2003;111(6 Pt
1):e706-713.
243. Sandrini A, Ferreira IM, Jardim JR, Zamel N, Chapman KR. Effect of nasal triamcinolone
acetonide on lower airway inflammatory markers in patients with allergic rhinitis. J Allergy Clin
Immunol 2003;111(2):313-320.
244. Sandrini A, Ferreira IM, Gutierrez C, Jardim JR, Zamel N, Chapman KR. Effect of
montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma. Chest
2003;124(4):1334-1340.
245. Sans-Torres J, Domingo C, Moron A, Rue M, Marin A, Saas-Torres J. Long-term effects of
almitrine bismesylate in COPD patients with chronic hypoxaemia. Respir Med 2003;97(6):599-605.
246. Sastre J, Fernandez-Nieto M, Rico P, Martin S, Barber D, Cuesta J, de las Heras M, Quirce
S. Specific immunotherapy with a standardized latex extract in allergic workers: a double-blind,
placebo-controlled study. J Allergy Clin Immunol 2003;111(5):985-994.
247. Schatz M, Rodriguez E, Falkoff R, Zeiger RS. The relationship of frequency of follow-up
visits to asthma outcomes in patients with moderate persistent asthma. J Asthma 2003;40(1):49-53.
248. Schmier J, Leidy NK, Gower R. Reduction in oral corticosteroid use with mometasone
furoate dry powder inhaler improves health-related quality of life in patients with severe persistent
asthma. J Asthma 2003;40(4):383-393.
249. Sekhar AV, Gandhi DN, Rao NM, Rawal UD. An experimental and clinical evaluation of
anti-asthmatic potentialities of Devadaru compound (DC). Indian J Physiol Pharmacol
2003;47(1):101-107.
250. Serrier P, Roche N, Pello JY, Larguier JS, Mezzi K. [Control of asthma by treatment with
inhaled corticosteroids and prolonged action beta 2-agonists in free or fixed combination. Results
of the ALISE study]. Presse Med 2003;32(11):493-497.
251. Sharma S, Godatwar P, Kulkarni LR. Salbutamol and/or beclomethasone diproprionate in
asthma. Indian J Pediatr 2003;70(2):129-132.
252. Sheikh S, Castile R, Hayes J, McCoy K, Eid N. Assessing bronchodilator responsiveness in
infants using partial expiratory flow-volume curves. Pediatr Pulmonol 2003;36(3):196-201.
253. Sheth K, Bernstein JA, Lincourt WR, Merchant KK, Edwards LD, Crim CC, Dorinsky PM.
Patient perceptions of an inhaled asthma medication administered as an inhalation powder via the
Diskus or as an inhalation aerosol via a metered-dose inhaler. Ann Allergy Asthma Immunol
2003;91(1):55-60.
254. Silverman EK, Kwiatkowski DJ, Sylvia JS, Lazarus R, Drazen JM, Lange C, Laird NM,
Weiss ST. Family-based association analysis of beta2-adrenergic receptor polymorphisms in the
childhood asthma management program. J Allergy Clin Immunol 2003;112(5):870-876.
255. Simpson A, Simpson B, Custovic A, Craven M, Woodcock A. Stringent environmental
control in pregnancy and early life: the long-term effects on mite, cat and dog allergen. Clin Exp
Allergy 2003;33(9):1183-1189.
256. Sims EJ, Jackson CM, Lipworth BJ. Add-on therapy with montelukast or formoterol in
patients with the glycine-16 beta2-receptor genotype. Br J Clin Pharmacol 2003;56(1):104-111.
257. Sitkauskiene B, Sakalauskas R, Malakauskas K, Lotvall J. Reversibility to a beta2-agonist
in COPD: relationship to atopy and neutrophil activation. Respir Med 2003;97(6):591-598.
258. Sjosward KN, Josefsson M, Ahlner J, Schmekel B. Preserved bronchial dilatation after
salbutamol does not guarantee protection against bronchial hyperresponsiveness. Clin Physiol
Funct Imaging 2003;23(1):14-20.
259. Slaughter JC, Lumley T, Sheppard L, Koenig JQ, Shapiro GG. Effects of ambient air
pollution on symptom severity and medication use in children with asthma. Ann Allergy Asthma
Immunol 2003;91(4):346-353.
260. Smith PL, O'Donnell CP, Allan L, Schwartz AR. A physiologic comparison of nasal and
oral positive airway pressure. Chest 2003;123(3):689-694.
261. Sontag SJ, O'Connell S, Khandelwal S, Greenlee H, Schnell T, Nemchausky B, Chejfec G,
Miller T, Seidel J, Sonnenberg A. Asthmatics with gastroesophageal reflux: long term results of a
randomized trial of medical and surgical antireflux therapies. Am J Gastroenterol 2003;98(5):987999.
262. Soroksky A, Stav D, Shpirer I. A pilot prospective, randomized, placebo-controlled trial of
bilevel positive airway pressure in acute asthmatic attack. Chest 2003;123(4):1018-1025.
263. Spicuzza L, Ciancio N, Pellegrino R, Bellofiore S, Polosa R, Ricciardolo FL, Brusasco V,
Di Maria GU. The effect of inhaled furosemide and acetazolamide on bronchoconstriction induced
by deep inspiration in asthma. Monaldi Arch Chest Dis 2003;59(2):150-154.
264. Stahl E, Postma DS, Svensson K, Tattersfield AE, Eivindson A, Schreurs A, Lofdahl CG.
Formoterol used as needed improves health-related quality of life in asthmatic patients uncontrolled
with inhaled corticosteroids. Respir Med 2003;97(9):1061-1066.
265. Stallberg B, Olsson P, Jorgensen LA, Lindarck N, Ekstrom T. Budesonide/formoterol
adjustable maintenance dosing reduces asthma exacerbations versus fixed dosing. Int J Clin Pract
2003;57(8):656-661.
266. Stelmach I, Jerzynska J, Stelmach W, Majak P, Brzozowska A, Gorski P, Kuna P. The
effect of inhaled heparin on airway responsiveness to histamine and leukotriene D4. Allergy
Asthma Proc 2003;24(1):59-65.
267. Stephens RE, Addington WR, Widdicombe JG. Effect of acute unilateral middle cerebral
artery infarcts on voluntary cough and the laryngeal cough reflex. Am J Phys Med Rehabil
2003;82(5):379-383.
268. Strunk RC, Szefler SJ, Phillips BR, Zeiger RS, Chinchilli VM, Larsen G, Hodgdon K,
Morgan W, Sorkness CA, Lemanske RF, Jr. Relationship of exhaled nitric oxide to clinical and
inflammatory markers of persistent asthma in children. J Allergy Clin Immunol 2003;112(5):883892.
269. Surette ME, Koumenis IL, Edens MB, Tramposch KM, Clayton B, Bowton D, Chilton FH.
Inhibition of leukotriene biosynthesis by a novel dietary fatty acid formulation in patients with
atopic asthma: a randomized, placebo-controlled, parallel-group, prospective trial. Clin Ther
2003;25(3):972-979.
270. Swierczynska M, Nizankowska-Mogilnicka E, Zarychta J, Gielicz A, Szczeklik A. Nasal
versus bronchial and nasal response to oral aspirin challenge: Clinical and biochemical differences
between patients with aspirin-induced asthma/rhinitis. J Allergy Clin Immunol 2003;112(5):9951001.
271. Tanaka S, Tanaka H, Abe S. High dose of inhaled fluticasone reduces high levels of urinary
leukotriene E4 in the early morning in mild and moderate nocturnal asthma. Chest
2003;124(5):1768-1773.
272. Tantisira KG, Litonjua AA, Weiss ST, Fuhlbrigge AL. Association of body mass with
pulmonary function in the Childhood Asthma Management Program (CAMP). Thorax
2003;58(12):1036-1041.
273. Taube C, Kanniess F, Gronke L, Richter K, Mucke M, Paasch K, Eichler G, Jorres RA,
Magnussen H. Reproducibility of forced inspiratory and expiratory volumes after bronchodilation
in patients with COPD or asthma. Respir Med 2003;97(5):568-577.
274. Taylor AJ. HLA phenotype and exposure in development of occupational asthma. Ann
Allergy Asthma Immunol 2003;90(5 Suppl 2):24-27.
275. Terreehorst I, Hak E, Oosting AJ, Tempels-Pavlica Z, de Monchy JG, Bruijnzeel-Koomen
CA, Aalberse RC, Gerth van Wijk R. Evaluation of impermeable covers for bedding in patients
with allergic rhinitis. N Engl J Med 2003;349(3):237-246.
276. Terzano C, Ricci A, Burinschi V, Nekam K, Lahovsky J. Comparison of the efficacy of
beclometasone dipropionate and fluticasone propionate suspensions for nebulization in adult
patients with persistent asthma. Respir Med 2003;97 Suppl B:S35-40.
277. Thole H, Weingart O, Lampert U, Bassler D, Fessler J, Forster J, Franzen D, Geraedts M,
Kroegel C, Morike K, Schmitz M, Scholz R, Teske S, Ollenschlager G. [The German guideline
clearing-project on bronchial asthma-part 1: Methodology and results of formal appraisal].
Pneumologie 2003;57(8):459-467.
278. Thomas M, McKinley RK, Freeman E, Foy C, Prodger P, Price D. Breathing retraining for
dysfunctional breathing in asthma: a randomised controlled trial. Thorax 2003;58(2):110-115.
279. Thoonen BP, Schermer TR, Van Den Boom G, Molema J, Folgering H, Akkermans RP,
Grol R, Van Weel C, Van Schayck CP. Self-management of asthma in general practice, asthma
control and quality of life: a randomised controlled trial. Thorax 2003;58(1):30-36.
280. Tinkelman DG, Bronsky EA, Gross G, Schoenwetter WF, Spector SL. Efficacy and safety
of budesonide inhalation powder (Pulmicort Turbuhaler) during 52 weeks of treatment in adults
and children with persistent asthma. J Asthma 2003;40(3):225-236.
281. Tonelli M, Zingoni M, Bacci E, Dente FL, Di Franco A, Giannini D, Taccola M, Vagaggini
B, Paggiaro PL. Short-term effect of the addition of leukotriene receptor antagonists to the current
therapy in severe asthmatics. Pulm Pharmacol Ther 2003;16(4):237-240.
282. Tosca MA, Cosentino C, Pallestrini E, Caligo G, Milanese M, Ciprandi G. Improvement of
clinical and immunopathologic parameters in asthmatic children treated for concomitant chronic
rhinosinusitis. Ann Allergy Asthma Immunol 2003;91(1):71-78.
283. Tsao CH, Chen LC, Yeh KW, Huang JL. Concomitant chronic sinusitis treatment in
children with mild asthma: the effect on bronchial hyperresponsiveness. Chest 2003;123(3):757764.
284. Tunnicliffe WS, Harrison RM, Kelly FJ, Dunster C, Ayres JG. The effect of sulphurous air
pollutant exposures on symptoms, lung function, exhaled nitric oxide, and nasal epithelial lining
fluid antioxidant concentrations in normal and asthmatic adults. Occup Environ Med
2003;60(11):e15.
285. Vacca P, Carbone R, Monselise A, Grosso M, Bottino G. Neurotensin pulmonary
metabolism in normal and asthmatic subjects. Eur Rev Med Pharmacol Sci 2003;7(3):75-80.
286. van Veen A, Weller FR, Wierenga EA, Jansen HM, Jonkers RE. A comparison of
salmeterol and formoterol in attenuating airway responses to short-acting beta2-agonists. Pulm
Pharmacol Ther 2003;16(3):153-161.
287. Vaquerizo MJ, Casan P, Castillo J, Perpina M, Sanchis J, Sobradillo V, Valencia A, Verea
H, Viejo JL, Villasante C, Gonzalez-Esteban J, Picado C. Effect of montelukast added to inhaled
budesonide on control of mild to moderate asthma. Thorax 2003;58(3):204-210.
288. Varney VA, Tabbah K, Mavroleon G, Frew AJ. Usefulness of specific immunotherapy in
patients with severe perennial allergic rhinitis induced by house dust mite: a double-blind,
randomized, placebo-controlled trial. Clin Exp Allergy 2003;33(8):1076-1082.
289. Varshavskii B, Trubnikov GV, Galaktipmpva LP, Koreniak NA, Koledeznaia IL,
Oberemok AN. [Oxidant-antioxidant status of patients with bronchial asthma during inhalation and
systemic glucocorticoid therapy]. Ter Arkh 2003;75(3):21-24.
290. Verona E, Petrov D, Cserhati E, Hofman J, Geppe N, Medley H, Hughes S. Fluticasone
propionate in asthma: a long term dose comparison study. Arch Dis Child 2003;88(6):503-509.
291. Verstappen WH, van der Weijden T, Sijbrandij J, Smeele I, Hermsen J, Grimshaw J, Grol
RP. Effect of a practice-based strategy on test ordering performance of primary care physicians: a
randomized trial. JAMA 2003;289(18):2407-2412.
292. Vincken W, Dewberry H, Moonen D. Fenoterol delivery by Respimat soft mist inhaler
versus CFC metered dose inhaler: cumulative dose-response study in asthma patients. J Asthma
2003;40(6):721-730.
293. Volovitz B, Nussinovitch M. Effect of high starting dose of budesonide inhalation
suspension on serum cortisol concentration in young children with recurrent wheezing episodes. J
Asthma 2003;40(6):625-629.
294. Wajima Z, Yoshikawa T, Ogura A, Imanaga K, Shiga T, Inoue T, Ogawa R. Intravenous
nicorandil prevents thiamylal-fentanyl-induced bronchoconstriction in humans. Crit Care Med
2003;31(2):485-490.
295. Wallin A, Sue-Chu M, Bjermer L, Ward J, Sandstrom T, Lindberg A, Lundback B,
Djukanovic R, Holgate S, Wilson S. Effect of inhaled fluticasone with and without salmeterol on
airway inflammation in asthma. J Allergy Clin Immunol 2003;112(1):72-78.
296. Wark PA, Hensley MJ, Saltos N, Boyle MJ, Toneguzzi RC, Epid GD, Simpson JL,
McElduff P, Gibson PG. Anti-inflammatory effect of itraconazole in stable allergic
bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol
2003;111(5):952-957.
297. Weidner T, Schurr T. Effect of exercise on upper respiratory tract infection in sedentary
subjects. Br J Sports Med 2003;37(4):304-306.
298. Weisgerber MC, Guill M, Weisgerber JM, Butler H. Benefits of swimming in asthma:
effect of a session of swimming lessons on symptoms and PFTs with review of the literature. J
Asthma 2003;40(5):453-464.
299. White A, Slade P, Hunt C, Hart A, Ernst E. Individualised homeopathy as an adjunct in the
treatment of childhood asthma: a randomised placebo controlled trial. Thorax 2003;58(4):317-321.
300. Willemse BW, Toelle BG, Li JS, Shah S, Peat JK. Use of a paper disposable cup as a spacer
is effective for the first-aid management of asthma. Respir Med 2003;97(1):86-89.
301. Williams SG, Schmidt DK, Redd SC, Storms W. Key clinical activities for quality asthma
care. Recommendations of the National Asthma Education and Prevention Program. MMWR
Recomm Rep 2003;52(RR-6):1-8.
302. Wilson AM, Coutie WJ, Sims EJ, Lipworth BJ. The skin vasoconstrictor assay does not
correlate significantly to airway or systemic responsiveness to inhaled budesonide in asthmatic
patients. Eur J Clin Pharmacol 2003;58(10):643-647.
303. Wolf FM, Guevara JP, Grum CM, Clark NM, Cates CJ. Educational interventions for
asthma in children. Cochrane Database Syst Rev 2003(1):CD000326.
304. Wong WM, Lai KC, Lam KF, Hui WM, Hu WH, Lam CL, Xia HH, Huang JQ, Chan CK,
Lam SK, Wong BC. Prevalence, clinical spectrum and health care utilization of gastro-oesophageal
reflux disease in a Chinese population: a population-based study. Aliment Pharmacol Ther
2003;18(6):595-604.
305. Wood LG, Gibson PG, Garg ML. Biomarkers of lipid peroxidation, airway inflammation
and asthma. Eur Respir J 2003;21(1):177-186.
306. Woodcock A, Forster L, Matthews E, Martin J, Letley L, Vickers M, Britton J, Strachan D,
Howarth P, Altmann D, Frost C, Custovic A. Control of exposure to mite allergen and allergenimpermeable bed covers for adults with asthma. N Engl J Med 2003;349(3):225-236.
307. Wormald PJ. Salvage frontal sinus surgery: the endoscopic modified Lothrop procedure.
Laryngoscope 2003;113(2):276-283.
308. Wraight JM, Hancox RJ, Herbison GP, Cowan JO, Flannery EM, Taylor DR.
Bronchodilator tolerance: the impact of increasing bronchoconstriction. Eur Respir J
2003;21(5):810-815.
309. Xie L, Liu Y, Chen L, Hao F, Jin G, Zhao H. Inhaling beta(2)-agonist with heliox-driven in
bronchial asthma. Chin Med J (Engl) 2003;116(7):1011-1015.
310. Yoos HL, Kitzman H, McMullen A, Sidora K. Symptom perception in childhood asthma:
how accurate are children and their parents? J Asthma 2003;40(1):27-39.
311. Zhang X, Wang L, Shi Q. [Effect of fluticasone inhalation combined with xiaoqinglong
decoction on pulmonary function and serum interleukin-16 level in asthma patients]. Zhongguo
Zhong Xi Yi Jie He Za Zhi 2003;23(6):426-429.
312. Zorc JJ, Scarfone RJ, Li Y, Hong T, Harmelin M, Grunstein L, Andre JB. Scheduled
follow-up after a pediatric emergency department visit for asthma: a randomized trial. Pediatrics
2003;111(3):495-502.